UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Evaluation of the secondary use of electronic health records to detect seasonal, holiday-related, and rare events related to traumatic injury and poisoning

BMC public health, 2020-01, Vol.20 (1), p.46-13, Article 46

2020

Volltextzugriff (PDF)

Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma

Blood cancer journal (New York), 2023-12, Vol.13 (1), p.180-180, Article 180

2023

Volltextzugriff (PDF)

A framework for future national pediatric pandemic respiratory disease severity triage: The HHS pediatric COVID-19 data challenge

Journal of clinical and translational science, 2023-01, Vol.7 (1), p.e175, Article e175

2023

Volltextzugriff (PDF)

Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C)

Journal of clinical oncology, 2021-07, Vol.39 (20), p.2232-2246

2021

Volltextzugriff (PDF)

Dolphin-Assisted Therapy for Children With Special Needs: A Pilot Study

Journal of creativity in mental health, 2011-01, Vol.6 (1), p.56-68

2011

Volltextzugriff (PDF)

Risk and Outcome of Breakthrough COVID-19 Infections in Vaccinated Patients With Cancer: Real-World Evidence From the National COVID Cohort Collaborative

Journal of clinical oncology, 2022-05, Vol.40 (13), p.1414-1427

2022

Volltextzugriff (PDF)

A Bookstore for Bailey: A Novel Approach to Teaching a Small-Business Management Course

Decision sciences journal of innovative education, 2011-05, Vol.9 (2), p.269-274

2011

Volltextzugriff (PDF)

SARS-CoV-2 infection and COVID-19 severity in individuals with prior seasonal coronavirus infection

Diagnostic microbiology and infectious disease, 2021-06, Vol.100 (2), p.115338-115338, Article 115338

2021

Volltextzugriff (PDF)

Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: A retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C)

Seminars in arthritis and rheumatism, 2023-02, Vol.58, p.152149-152149, Article 152149

2023

Volltextzugriff (PDF)

Reply to K. Takada et al

Journal of clinical oncology, 2021-12, Vol.39 (35), p.3997-3998

2021

Volltextzugriff (PDF)

Piloting a model-to-data approach to enable predictive analytics in health care through patient mortality prediction

Journal of the American Medical Informatics Association : JAMIA, 2020-09, Vol.27 (9), p.1393-1400

2020

Volltextzugriff (PDF)

Long COVID-19 in patients with cancer: Report from the National COVID Cohort Collaborative (N3C)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.1540-1540

2022

Volltextzugriff (PDF)

Major risk factors associated with severe COVID-19 outcomes in patients with multiple myeloma: Report from the National COVID-19 Cohort Collaborative (N3C)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.8008-8008

2022

Volltextzugriff (PDF)

COVID-19 omicron variants demonstrated different virulence in infected patients with cancer: The real-world evidence from the National COVID Cohort Collaborative (N3C)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18672-e18672

2022

Volltextzugriff (PDF)

Outcomes of 92 patient-driven family studies for reclassification of variants of uncertain significance

Genetics in medicine, 2019-06, Vol.21 (6), p.1435-1442

2019

Volltextzugriff (PDF)

Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: a retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C): Rituximab is associated with worse COVID-19 outcomes

Seminars in arthritis and rheumatism, 2022-12

2022

Volltextzugriff (PDF)

Outcomes of COVID-19 in cancer patients: Report from the National COVID Cohort Collaborative (N3C)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.1500-1500

2021

Volltextzugriff (PDF)

Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes

EBioMedicine, 2023-01, Vol.87 (C), p.104413-104413, Article 104413

2023

Volltextzugriff (PDF)

Assessment of the evidence yield for the calibrated PP3/BP4 computational recommendations

Genetics in medicine, 2024-07, p.101213, Article 101213

2024

Volltextzugriff (PDF)

Ensuring Patient Privacy and Accuracy of Analytical Methods to Support Evidence-Based Healthcare

Bergquist, Timothy R

2021

Volltextzugriff (PDF)

Evaluation of crowdsourced mortality prediction models as a framework for assessing artificial intelligence in medicine

Journal of the American Medical Informatics Association : JAMIA, 2023-12, Vol.31 (1), p.35-44

2023

Volltextzugriff (PDF)

Does Frailty influence Inhospital Management and Outcomes of COVID-19 in Older Adults in the US?

Innovation in aging, 2021-12, Vol.5 (Supplement_1), p.966-966

2021

Volltextzugriff (PDF)

The CAFA challenge reports improved protein function prediction and new functional annotations for hundreds of genes through experimental screens

Genome Biology, 2019-11, Vol.20 (1), p.244-244, Article 244

2019

Volltextzugriff (PDF)

Heart on FHIR: Integrating Patient Generated Data into Clinical Care to Reduce 30 Day Heart Failure Readmissions (Extended Abstract)

AMIA ... Annual Symposium proceedings, 2017, Vol.2017, p.2269-2273

2017

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(43)

Publikationsform

Sprache

Englisch
(49)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Evaluation of the secondary use of electronic health records to detect seasonal, holiday-related, and rare events related to traumatic injury and poisoning

Mapping genetic variations to three-dimensional protein structures to enhance variant interpretation: a proposed framework

Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma

A framework for future national pediatric pandemic respiratory disease severity triage: The HHS pediatric COVID-19 data challenge

Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C)

Dolphin-Assisted Therapy for Children With Special Needs: A Pilot Study

Risk and Outcome of Breakthrough COVID-19 Infections in Vaccinated Patients With Cancer: Real-World Evidence From the National COVID Cohort Collaborative

A Bookstore for Bailey: A Novel Approach to Teaching a Small-Business Management Course

SARS-CoV-2 infection and COVID-19 severity in individuals with prior seasonal coronavirus infection

Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: A retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C)

Reply to K. Takada et al

Piloting a model-to-data approach to enable predictive analytics in health care through patient mortality prediction

Long COVID-19 in patients with cancer: Report from the National COVID Cohort Collaborative (N3C)

Major risk factors associated with severe COVID-19 outcomes in patients with multiple myeloma: Report from the National COVID-19 Cohort Collaborative (N3C)

COVID-19 omicron variants demonstrated different virulence in infected patients with cancer: The real-world evidence from the National COVID Cohort Collaborative (N3C)

Outcomes of 92 patient-driven family studies for reclassification of variants of uncertain significance

Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: a retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C): Rituximab is associated with worse COVID-19 outcomes

Outcomes of COVID-19 in cancer patients: Report from the National COVID Cohort Collaborative (N3C)

Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes

Assessment of the evidence yield for the calibrated PP3/BP4 computational recommendations

Ensuring Patient Privacy and Accuracy of Analytical Methods to Support Evidence-Based Healthcare

Evaluation of crowdsourced mortality prediction models as a framework for assessing artificial intelligence in medicine

Does Frailty influence Inhospital Management and Outcomes of COVID-19 in Older Adults in the US?

The CAFA challenge reports improved protein function prediction and new functional annotations for hundreds of genes through experimental screens

Heart on FHIR: Integrating Patient Generated Data into Clinical Care to Reduce 30 Day Heart Failure Readmissions (Extended Abstract)

Suchergebnisse filtern